CARISOPRODOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carisoprodol, and when can generic versions of Carisoprodol launch?
Carisoprodol is a drug marketed by Able, Accelrx Labs, Allied, Aurobindo Pharma, Chartwell Rx, Epic Pharma Llc, Hikma Intl Pharms, Natco, Nostrum Labs Inc, Novast Labs, Orient Pharma Co Ltd, Oxford Pharms, Pioneer Pharms, Sandoz, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Sun Pharm Industries, Wanbang Biopharms, Watson Labs, Watson Labs Teva, Wilshire Pharms Inc, Genus, and Ingenus Pharms Nj. and is included in thirty-two NDAs.
The generic ingredient in CARISOPRODOL is aspirin; carisoprodol; codeine phosphate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARISOPRODOL?
- What are the global sales for CARISOPRODOL?
- What is Average Wholesale Price for CARISOPRODOL?
Summary for CARISOPRODOL
| US Patents: | 0 |
| Applicants: | 24 |
| NDAs: | 32 |
| Finished Product Suppliers / Packagers: | 25 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Clinical Trials: | 4 |
| Patent Applications: | 3,864 |
| Drug Prices: | Drug price information for CARISOPRODOL |
| What excipients (inactive ingredients) are in CARISOPRODOL? | CARISOPRODOL excipients list |
| DailyMed Link: | CARISOPRODOL at DailyMed |
See drug prices for CARISOPRODOL
Recent Clinical Trials for CARISOPRODOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Farmoquimica S.A. | Phase 3 |
| Pharmagenix Projetos em Medicina Farmacêutica Ltda. | Phase 3 |
Pharmacology for CARISOPRODOL
| Drug Class | Muscle Relaxant |
| Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for CARISOPRODOL
Anatomical Therapeutic Chemical (ATC) Classes for CARISOPRODOL
US Patents and Regulatory Information for CARISOPRODOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxford Pharms | CARISOPRODOL AND ASPIRIN | aspirin; carisoprodol | TABLET;ORAL | 040252-001 | Dec 10, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wilshire Pharms Inc | CARISOPRODOL | carisoprodol | TABLET;ORAL | 205126-002 | Jul 8, 2015 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | CARISOPRODOL COMPOUND | aspirin; carisoprodol | TABLET;ORAL | 088809-001 | Oct 3, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
